Aggregation induced emission of fluorescent bioprobes and methods of using the same

US9618453B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9618453-B2
Application numberUS-201313899070-A
CountryUS
Kind codeB2
Filing dateMay 21, 2013
Priority dateOct 11, 2011
Publication dateApr 11, 2017
Grant dateApr 11, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are fluorescent bioprobes comprising fluorogens that exhibit aggregation-induced emission (AIE) labeled on biomolecules. The present subject matter relates to a fluorescent bioprobe comprising one or more fluorogen labeled on chitosan. The present subject matter is also directed to methods of preparing the fluorescent bioprobes, methods of labeling and detecting DNA and/or proteins with the fluorescent bioprobe, and methods of cell imaging including live cell tracking.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of preparing a fluorescent bioprobe comprising the following steps: (i) synthesizing fluorogens with one or more amine- or thiol-reactive functional groups; and (ii) labeling a biomolecule with the fluorogens via a reaction between the fluorogens and one or more amine or thiol groups of the biomolecule; wherein the one or more amine- or thiol-reactive functional groups are selected from the group consisting of isocyanates, isothiocyanates, aldehydes, succinimidyl esters, 4-sulfotetrafluorophenyl esters, 2,4,5,6-tetrafluorophenyl esters, sulfodicholorphenol esters, carbonyl azides, sulfonyl chlorides, and haloacetamides; wherein the fluorescent bioprobe emits fluorescence; wherein the fluorogens exhibit aggregation-induced emission and comprise a backbone structure selected from the group consisting of: wherein: each R and R′ are independently selected from the group consisting of: H, C n H 2n+1 , OC n H 2n+1 , C 6 H 5 , OC 6 H 5 , and (X) n N[(CH 2 ) m CH 3 ] 2 ; X is selected from the group consisting of (CH 2 ) n , C 6 H 5 , and O(CH 2 ) n ; and n, m independently=an integer from 0 to 20; and wherein the biomolecule is one or more selected from the group consisting of a nucleotide, nucleoside, oligonucleotide, and DNA, each comprising a reactive thiol or amine group, proteins, and chitosan. 2. The method of claim 1 , wherein the labeling is carried out without a fixation process. 3. The method of claim 1 , wherein the labeling step is carried out without self-quenching. 4. A method of in vitro cell imaging comprising: (a) contacting cells with a fluorescent bioprobe; and (b) detecting cellular fluorescence via fluorescent microscopy, wherein the fluorescent bioprobe comprises a biomolecule covalently conjugated with one or more fluorogens; wherein the fluorescent bioprobe emits fluorescence; wherein the one or more fluorogens exhibit aggregation-induced emission and comprise a backbone structure selected from the group consisting of: wherein: each R and R′ are independently selected from the group consisting of: H, C n H 2n+1 , OC n H 2n+1 , C 6 H 5 , OC 6 H 5 , and (X) n N[(CH 2 ) m CH 3 ] 2 ; X is selected from the group consisting of (CH 2 ) n , C 6 H 5 , and O(CH 2 ) n ; and n, m independently=an integer from 0 to 20; and wherein the biomolecule is selected from the group consisting of nucleosides, nucleotides, and oligonucleotides. 5. The method of claim 4 , wherein the fluorescent microscopy is used for live cell tracking. 6. The method of claim 4 , wherein the cells uptake the fluorescent bioprobe. 7. The method of claim 6 , wherein the one or more fluorogens interact with the biomolecule inside cells via electrostatic attraction, hydrogen bonding, or hydrophobic interaction. 8. A method of in vitro cellular imaging comprising: contacting target cells with a fluorescent bioprobe comprising luminogen formed nanoparticles for cellular imaging and long term cellular tracking comprising one or more luminogens that exhibit aggregation-induced emission properties; wherein the luminogen formed nanoparticles are fully retained inside living cells and have a fluorescence emission; wherein the one or more luminogens are represented by the structure: wherein each R and R′ are independently selected from the group consisting of: H, C n H 2n+1 , OC n H 2n+1 , C 6 H 5 , OC 6 H 5 , and (X) n N[(CH 2 ) m CH 3 ] 2 ; X is selected from the group consisting of (CH 2 ) n , C 6 H 5 , and O(CH 2 ) n ; and n, m independently=an integer from 0 to 20; and detecting cellular fluorescence. 9. A method of in vitro cell imaging comprising: (a) contacting cells with a fluorescent bioprobe; and (b) detecting cellular fluorescence via fluorescent microscopy, wherein the fluorescent bioprobe comprises a biomolecule covalently conjugated with one or more fluorogens; wherein the fluorescent bioprobe emits fluorescence; and wherein the one or more fluorogens exhibit aggregation-induced emission and are represented by the structure:

Assignees

Inventors

Classifications

  • with indicators, stains, dyes, tags, labels, marks · CPC title

  • Fluorescence microscopy (fluorescence microscopes per se G02B21/0076 and G02B21/16) · CPC title

  • Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence) · CPC title

  • Chemistry & Metallurgy · mapped topic

  • Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9618453B2 cover?
Provided herein are fluorescent bioprobes comprising fluorogens that exhibit aggregation-induced emission (AIE) labeled on biomolecules. The present subject matter relates to a fluorescent bioprobe comprising one or more fluorogen labeled on chitosan. The present subject matter is also directed to methods of preparing the fluorescent bioprobes, methods of labeling and detecting DNA and/or prote…
Who is the assignee on this patent?
Univ Hong Kong Science & Tech
What technology area does this patent fall under?
Primary CPC classification G01N21/6486. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).